|
GTF3C3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.5211399999937E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.221900E-03 |
| Normal-vs-Stage2 |
3.410000E-02 |
| Normal-vs-Stage3 |
6.20760000069609E-08 |
| Normal-vs-Stage4 |
1.626880E-04 |
| Stage1-vs-Stage2 |
7.489200E-01 |
| Stage1-vs-Stage3 |
4.191200E-04 |
| Stage1-vs-Stage4 |
3.863500E-02 |
| Stage2-vs-Stage3 |
4.618400E-02 |
| Stage2-vs-Stage4 |
1.976350E-01 |
| Stage3-vs-Stage4 |
6.896600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.60410000002742E-06 |
| Normal-vs-AfricanAmerican |
3.276600E-03 |
| Normal-vs-Asian |
6.555800E-01 |
| Caucasian-vs-AfricanAmerican |
7.190400E-01 |
| Caucasian-vs-Asian |
1.040170E-01 |
| AfricanAmerican-vs-Asian |
1.184230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.60859999998442E-07 |
| Normal-vs-Female |
6.158100E-03 |
| Male-vs-Female |
2.019700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.538610E-03 |
| Normal-vs-Age(41-60Yrs) |
7.426300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.71540999999165E-05 |
| Normal-vs-Age(81-100Yrs) |
3.810500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.344200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.128200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.258200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.366800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.855400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.735000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.150800E-01 |
| Normal-vs-Grade 2 |
5.736900E-03 |
| Normal-vs-Grade 3 |
5.98960000042226E-07 |
| Normal-vs-Grade 4 |
4.04080000004914E-06 |
| Grade 1-vs-Grade 2 |
1.822180E-01 |
| Grade 1-vs-Grade 3 |
2.012100E-02 |
| Grade 1-vs-Grade 4 |
1.829860E-02 |
| Grade 2-vs-Grade 3 |
7.157300E-03 |
| Grade 2-vs-Grade 4 |
3.222600E-03 |
| Grade 3-vs-Grade 4 |
1.670410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.027600E-02 |
| Normal-vs-ccB subtype |
3.70630000001704E-06 |
| ccA subtype-vs-ccB subtype |
1.135410E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.573110E-04 |
| Normal-vs-N1 |
1.031790E-01 |
| N0-vs-N1 |
5.622200E-01 |
|
|
